The Role of SMEs in New Biobased Value Chains Roger A. Sheldon CEO CLEA Technologies Stakeholder Event Biobased Public Private Partnership ‘BRIDGE’ Beatrix Gebouw, Jaarbeurs, Utrecht 21 May, 2013
The Value Chain Integrated biobased value chains
Bridging the pillars – towards the Biobased Economy
BRIDGE: the focus • Build new interconnections between different sectors • Build new biobased value chains (from feedstock to products) • Establish new co-operations throughout industry clusters • Develop innovative and sustainable biobased chemicals and materials with locally sourced biomass and validated at demonstration scale • At least 5 flagships resulting from the PPP producing new biobased materials, chemicals and fuels proven to be cost- competitive to the alternatives based on fossil resources
SMEs in the innovation chain
BRIDGE: the role of SMEs • Substantial role innovative SMEs in transition to a biobased economy. • Specific technologies, services and equipment, enhancing developments at large enterprises and in stand alone projects. • Capturing the potential of new technologies extremely fast, thus driving the biobased economy as a whole. • Supportive measures for SMEs regarding financing, market info, legal obstacles and international partnering. • Representation via SME clusters or individual membership.
Current individual SME members • Inkemia IUCT group ( www.inkemia.com) - high-tech company for industrial technological innovation , developing and implementing new technologies in the chemical, pharmaceutical, and environmental fields. • CLEA Technologies ( www.cleatechnologies.com ) - develops green, biocatalytic processes and has proprietary technology for enzyme immobilization as Cross-Linked Enzyme Aggregates (CLEAs). • Direvo (www.direvo.com) - develops and implements biology-based solutions for partners and customers in the fast growing biomass conversion market. • Biobase Europe Pilot Plant (www.bbeu.org) - open innovation pilot and demo facilities for the biobased economy. • Bioprocess Pilot Facility ( www.tudelft.n l) – cooperation South-Holland, City of Delft, TU Delft, CSM/Purac, DSM, other BE-Basic partners. • BioNET Ingenieria (www.bionet.com ) - provides equipment and engineering for biotech, chemical, food and pharma industries
CLEA Technologies: Overview • CLEA Technologies B.V. since 2002 • Currently 15 employees • Contract research in biocatalytic process development • Enzyme screening and immobilization • Proprietary patented technology - Cross Linked Enzyme Aggregates (CLEAs)
Products and Services Contract research: development of green biocatalytic processes Custom immobilization of enzymes on exclusive basis Off the shelf products - Immobilized Enzymes (CLEAs and other preparations) - Free Enzymes (consistent activity and technical service) - Discovery Platforms (selection of free or immobilized biocatalysts all available on industrial scale)
The Enzyme Value Chain CLEA Technologies Enzyme Producers Enzyme Customers Evonik Novozymes BASF Dupont Lonza DSM Pfizer • Adding value to the biocatalyst / biocatalytic process • Working proactively with the customer to find optimum solutions
Our Technology X-linking X-linking X-linking + Co- X-linking + Co- Precipitation Precipitation polymerization polymerization X-linking + X-linking + magnetic particles magnetic particles • “Simple” & Broadly Applicable • Cost-effective (no need for pure enzyme) • Short Time-to-Market (low development costs) • Scalable Protocols
What do we expect to achieve? • Establish new strategic technological cooperations • Develop new markets for CLEAs • New contract research projects • New consortia for subsidy proposals • Support w.r.t. market data, financing,legal obstacles, international partnering, etc.
Bridging the innovation / implementation gap SMEs as Technology Providers Biobased Biobased products research Thank you Any questions? www.bridge2020.eu
Recommend
More recommend
